Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Role of the recently identified dysadherin in E-cadherin adhesion molecule downregulation in head and neck cancer.

Literature DB >> 22105147

Role of the recently identified dysadherin in E-cadherin adhesion molecule downregulation in head and neck cancer.

Alexandros Georgolios¹, Anna Eleftheriadou, Anna Batistatou, Kostandinos Charalabopoulos.

Abstract

Dysadherin is a cancer-related cell membrane glycoprotein, recently identified, playing an important role in tumor progression and metastasis. In the present minireview article, we are focusing on the role of dysadherin in E-cadherin downregulation, the various expression patterns of the molecule in head and neck cancer as well as its potential role as a molecular target for future applications in diagnosis, clinical routine and prognosis of the disease.

Entities: Disease Gene

Mesh：

Substances：

Year: 2011 PMID： 22105147 DOI： 10.1007/s12032-011-0118-3

Source DB: PubMed Journal: Med Oncol ISSN： 1357-0560 Impact factor: 3.064

46 in total

1. Prognostic significance of dysadherin expression in patients with non-small cell lung cancer.

Authors: Masaya Tamura; Yasuhiko Ohta; Yoshio Tsunezuka; Isao Matsumoto; Kazuyuki Kawakami; Makoto Oda; Go Watanabe
Journal: J Thorac Cardiovasc Surg Date: 2005-09 Impact factor: 5.209

Review 2. Role and expression patterns of E-cadherin in head and neck squamous cell carcinoma (HNSCC).

Authors: A Georgolios; A Batistatou; L Manolopoulos; K Charalabopoulos
Journal: J Exp Clin Cancer Res Date: 2006-03

3. E-cadherin adhesion molecule and syndecan-1 expression in various thyroid pathologies.

Authors: A Mitselou; E Ioachim; D Peschos; K Charalabopoulos; M Michael; N J Agnantis; T Vougiouklakis
Journal: Exp Oncol Date: 2007-03

4. E-cadherin is a selective and strongly dominant prognostic factor in squamous cell carcinoma: a comparison of E-cadherin with desmosomal components.

Authors: Franz X Bosch; Claudia Andl; Ulrich Abel; Jürgen Kartenbeck
Journal: Int J Cancer Date: 2005-05-01 Impact factor: 7.396

5. Prognostic significance of dysadherin expression in tongue cancer: immunohistochemical analysis of 91 cases.

Authors: Yukihiro Nakanishi; Shingo Akimoto; Yasuto Sato; Yae Kanai; Michiie Sakamoto; Setsuo Hirohashi
Journal: Appl Immunohistochem Mol Morphol Date: 2004-12

6. Role of E-cadherins in development of lymphatic tumor emboli.

Authors: Anita Gupta; Charuhas G Deshpande; Sunil Badve
Journal: Cancer Date: 2003-05-01 Impact factor: 6.860

7. Clinicopathologic significance of dysadherin expression in cutaneous malignant melanoma: immunohistochemical analysis of 115 patients.

Authors: Aya Nishizawa; Yukihiro Nakanishi; Kimio Yoshimura; Yuko Sasajima; Naoya Yamazaki; Akifumi Yamamoto; Katsumi Hanada; Yae Kanai; Setsuo Hirohashi
Journal: Cancer Date: 2005-04-15 Impact factor: 6.860

Review 8. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers.

Authors: S Hirohashi
Journal: Am J Pathol Date: 1998-08 Impact factor: 4.307

9. Dysadherin expression in gastrointestinal stromal tumors (GISTs).

Authors: Jian Fang Liang; Hui Xia Zheng; Hong Xiao; Ning Li; Cai Xia Cheng; Hong Kun Wang
Journal: Pathol Res Pract Date: 2009-02-12 Impact factor: 3.250

10. In breast carcinoma dysadherin expression is correlated with invasiveness but not with E-cadherin.

Authors: A Batistatou; D Peschos; H Tsanou; A Charalabopoulos; Y Nakanishi; S Hirohashi; N J Agnantis; K Charalabopoulos
Journal: Br J Cancer Date: 2007-04-17 Impact factor: 7.640

5 in total

1. Genome-wide analysis of the nucleus accumbens identifies DNA methylation signals differentiating low/binge from heavy alcohol drinking.

Authors: Rita Cervera-Juanes; Larry J Wilhelm; Byung Park; Kathleen A Grant; Betsy Ferguson
Journal: Alcohol Date: 2016-11-10 Impact factor: 2.405